111, Inc. (YI)
NASDAQ: YI · IEX Real-Time Price · USD
1.065
+0.025 (2.40%)
At close: Jul 19, 2024, 4:00 PM
1.020
-0.045 (-4.23%)
Pre-market: Jul 22, 2024, 4:10 AM EDT
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $93.71 million as of July 22, 2024. Its market cap has decreased by -56.07% in one year.
Market Cap
93.71M
Enterprise Value
34.32M
1-Year Change
-56.07%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.14B to $93.71M, a decrease of -91.81%. That is a compound annual growth rate of -34.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 91.10M | -30.46% |
| Dec 29, 2023 | 131.00M | -47.95% |
| Dec 30, 2022 | 251.70M | -13.33% |
| Dec 31, 2021 | 290.40M | -49.08% |
| Dec 31, 2020 | 570.30M | 3.92% |
| Dec 31, 2019 | 548.80M | 7.86% |
| Dec 31, 2018 | 508.80M | -55.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensus Healthcare | 98.36M |
| Xtant Medical Holdings | 96.53M |
| Checkpoint Therapeutics | 96.44M |
| Anixa Biosciences | 94.10M |
| Aclaris Therapeutics | 94.07M |
| Assembly Biosciences | 93.29M |
| Asensus Surgical | 92.55M |
| LakeShore Biopharma | 92.26M |